Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Torii

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Torii's Japan sales performance.

Novartis grows in Q3 thanks to stellar performance of key drugs

Novartis grows in Q3 thanks to stellar performance of key drugs

The therapy is currently under regulatory review in Europe and Japan, with decisions expected in 2020. ... The FDA in the US is still investigating the data manipulation – Novartis CEO Vas Narasimhan (pictured below) has said however that “for both

Roche scores another FDA approval for Xofluza

Roche scores another FDA approval for Xofluza Roche holds worldwide rights to the drug, excluding Japan and Taiwan, which are retained exclusively by Shionogi.

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal

CHMP says OK to UCB/Amgen’s Evenity for osteoporosis after appeal UCB and Amgen now say they are hoping for an EMA approval before the end of the year, which will come after approvals for Evenity in the US and Japan earlier

Takeda offloads select portfolio to Acino ahead of Shire takeover

Takeda offloads select portfolio to Acino ahead of Shire takeover However, Takeda maintained that Shire will help it grow outside Japan, and increase the company’s pipeline in the process.

Gilead promotes Andrew Dickinson to CFO, increased M&A expected

Gilead promotes Andrew Dickinson to CFO, increased M&A expected The drug is already under review in Europe and Japan, with plans to file in the US soon.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Tapping the potential of rare diseases: A journey into uncharted territory
...
The 2019 WHO essential medicine list: Narrowing the access gap to innovative cancer treatments
The essential medicine list (EML) contains treatments considered to be the most effective and safe in targeting global health concerns. On 9 July 2019, the World Health Organization (WHO) published...
NICE
Evolution or revolution: the latest review of NICE methods
By Leela Barham...

Infographics